To investigate how the AS signature that we defined from bulk gliomas also contributes to the intratumoral heterogeneity in gliomas, we analyzed published full-length scRNA-Seq data from 7 patients with IDH-WT GBM and 7 patients with IDH-mut glioma (31). This evidence concerns the gene IDH1 and central nervous system cancer.